← Back to Search

IV placement with Virtual Reality for Pediatric Intravenous Placement

N/A
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study aims to prospectively investigate the use of virtual reality headsets on the placement of IVs in a pediatric emergency department, by comparing the first stick success rate, total number of attempts, and the time to successful IV placement between patients who use virtual reality headset technology during the placement and those who receive the standard of care IV placement when child life ( individuals with special training in aiding and augmenting pediatric coping skills) is not available. The investigators will also compare the patient and parent perception of pain and anxiety associated with the IV placement in both study groups. Finally, by detailing which medications have been given prior to use of the VR for IV placement the investigators may evaluate for possible synergistic effects of VR with prior medication administration.

Eligible Conditions
  • Pediatric Intravenous Placement
  • Virtual Reality Distraction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Successful IV placement with first attempt
Secondary outcome measures
Pre vs Post FACES revised pain Scale patients
Pre vs Post FACES revised pain scale parents
Pre vs Post Likert-Type Anxiety Scale - parents
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IV placement with Virtual RealityExperimental Treatment1 Intervention
Patient will have IV placed with Virtual Reality headset distraction
Group II: IV placement no Virtual realityActive Control1 Intervention
Patient will have IV placed in traditional manner, with no virtual reality headset
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

Seton Healthcare FamilyOTHER
26 Previous Clinical Trials
9,429 Total Patients Enrolled
University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,128 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby Apr 2025